Reuters logo
BRIEF-Erytech announces launch of investigator-initiated phase 2 study of eryaspase (GRASPA) for ALL
April 4, 2017 / 4:37 PM / 8 months ago

BRIEF-Erytech announces launch of investigator-initiated phase 2 study of eryaspase (GRASPA) for ALL

April 4 (Reuters) - Erytech Pharma Sa:

* Announces launch of investigator-initiated phase 2 study of eryaspase (GRASPA) for ALL

* Single arm, multi-center, multi-national phase 2 study is expected to enroll approximately 30 patients at 23 sites across seven Nordic and Baltic countries Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below